Showing results (1091-1100 of 1,395) with videos related to

Sort By:
Pageof 140
Alimentary Pharmacology & Therapeutics|December 21, 2004
Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled studyR L West, C J van der Woude, B E Hansen, et al.
British Journal of Cancer|February 3, 2005
Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervixM M L Green, G J Hutchison, H R Valentine, et al.
Lipids|December 7, 2020
Lipidomic Analysis of Plasma from Healthy Men and Women Shows Phospholipid Class and Molecular Species Differences between SexesAnnette L West, Louise V Michaelson, Elizabeth A Miles, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2013
Poor prognosis associated with human papillomavirus α7 genotypes in cervical carcinoma cannot be explained by intrinsic radiosensitivityJohn S Hall, Rohan Iype, Lucile S C Armenoult, et al.
Radiology|February 22, 2014
Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor modelYue Zhang, Sarah B White, Jodi R Nicolai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2017
A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer PatientsLingjian Yang, Janet Taylor, Amanda Eustace, et al.
Cancer Research|August 2, 2014
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer modelsYu Zhu, Brett L Knolhoff, Melissa A Meyer, et al.
Journal of Hepatology|August 15, 2015
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trialEleonora Scorletti, Annette L West, Lokpal Bhatia, et al.
European Journal of Gastroenterology & Hepatology|January 2, 2022
De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalationPepijn W A Thomas, Lisa J T Smits, Maarten Te Groen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 11, 2021
Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging StudyWilliam A Fahy, Farshid Homayoun-Valiani, Anthony Cahn, et al.
Pageof 140